Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4.
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Whey peptides in a yogurt-like product fermented by Lactobacillus helveticus CPN4 were fractionated by a Sep-pak C-18 cartridge followed by two-step reverse-phase HPLC.The antihypertensive activity was measured by systolic blood pressure in spontaneously hypertensive rats after oral administration of each fraction.Five major peptides in the final fraction were further purified by reverse-phase HPLC and were measured for these antihypertensive activities in spontaneously hypertensive rats.The only peptide in the final fraction that showed strong antihypertensive activity had a sequence of Tyr-Pro, which is found in a s1 -casein (CN), b-CN, and k-CN.The synthetic peptide Tyr-Pro yielded significant antihypertensive activity from 2 to 8 h after oral administration of 1 mg of peptide/kg of body weight, and the effect was maximal at 6 h after oral administration.The antihypertensive effect of the peptide was dependent on the peptide dosage from 0.1 to 10 mg of peptide/kg of body weight.The concentration of Tyr-Pro peptide increased during fermentation and reached about 8.1 mg/ml of whey in the pH 4.3 yogurt-like product.The antihypertensive peptide had a low inhibitory activity against angiotensin I-converting enzyme.The inhibition of 50% of the angiotensin I-converting enzyme (IC 50 ) was 720 mM. ( Key words: yogurt-like product, Lactobacillus helveticus, antihypertensive peptide, angiotensin Iconverting enzyme)Abbreviation key: ACE = angiotensin I-converting enzyme, Hip-His-Leu = hippuryl-L-histidyl-Lleucine, IC 50 = amount of peptide needed to inhibit 50% of the ACE activity, SBP = systolic blood pressure, SHR = spontaneously hypertensive rats.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A very small dipeptide Tyr-Pro, proved to be effective in blood pressure control as well (Yamamoto et al., 1999).”
From Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines (2016) · cites this paper as Yamamoto et al., 1999
Citations
Cites
Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung
Cushman, D. W., & Cheung, H. S. (1971) · Biochemical Pharmacology · doi:10.1016/0006-2952(71)90292-9 · Cited by 2,625
Purification and Characterization of Angiotensin I-Converting Enzyme Inhibitors from Sour Milk
Nakamura, Y., Yamamoto, N., Sakai, K., Okubo, A., Yamazaki, S., & Takano, T. (1995) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(95)76689-9 · Cited by 838 · cited 4×
“In the current study, the ACE inhibitory activity of the Tyr-Pro peptide (IC50 = 720 mM) was lower than the activities of the peptides Ile-Pro-Pro or Val-Pro-Pro ( 5 and 9 mM, respectively) ( 8 ).”
BackgroundMethodInfluentialSelf-citationNakamura, Y., Yamamoto, N., Sakai, K., & Takano, T. (1995) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(95)76745-5 · Cited by 555 · cited 2×
“The antihypertensive effect specific to milk fermented with L. helveticus has been reported (16) for spontaneously hypertensive rats ( SHR) . Recently, two antihypertensive peptides, Val-Pro-Pro and Ile-Pro-Pro, were purified from sour milk that was fermented with L. helveticus and Saccharomyces cerevisiae (8, 9 ). Th…”
BackgroundSelf-citationA placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects
Hata, Y., Yamamoto, M., Ohni, M., Nakajima, K., Nakamura, Y., & Takano, T. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/64.5.767 · Cited by 509 · cited 2×
“The systolic blood pressure of patients decreased significantly, by 14.1 ± 3.1 mm of Hg, after daily oral administration of 95 ml of sour milk over 8 wk ( 2 ).”
BackgroundInfluentialSelf-citationYamamoto, N., Akino, A., & Takano, T. (1994) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(94)77026-0 · Cited by 418 · cited 1×
“The ACE inhibitory activity was measured according to the method of Cuchman and Cheung ( 1 ) with modification ( 17 ).”
MethodSelf-citationCellular localization and regional distribution of an angiotensin II-forming chymase in the heart.
Urata, H., Boehm, K. D., Philip, A., Kinoshita, A., Gabrovsek, J., Bumpus, F. M., & Husain, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116325 · Cited by 398 · cited 1×
“Recently, the role of chymase as a major angiotensin II-forming enzyme in the heart and its vessels was reported ( 13 ).”
BackgroundThe physiology and biochemistry of the proteolytic system in lactic acid bacteria
Pritchard, G. G., & Coolbear, T. (1993) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.1993.tb00018.x · Cited by 310 · cited 1×
“Lactic acid bacteria have a proteolytic system that releases peptides from casein during fermentation ( 10 , 11, 12).”
BackgroundProteolytic enzymes of dairy starter cultures
Thomas, T. D., & Pritchard, G. G. (1987) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1987.tb02464.x · Cited by 279
Masuda, O., Nakamura, Y., & Takano, T. (1996) · The Journal of Nutrition · doi:10.1093/jn/126.12.3063 · Cited by 264
Self-citationSaito, Y., Wanezaki (Nakamura), K., Kawato, A., & Imayasu, S. (1994) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.58.1767 · Cited by 240 · cited 1×
“A Tyr-Pro peptide from sake and sake lees was antihypertensive ( 19 ).”
Background
Research works printed but not linked: 1
- Yamamoto, 1997, Antihypertensive peptides derived from food proteins, Biopolymers, 43, 129, 10.1002/(SICI)1097-0282(1997)43:2<129::AID-BIP5>3.0.CO;2-X · DOI · Paper page
Cited by
Bioactive peptides: Production and functionality
Korhonen, H., & Pihlanto, A. (2006) · International Dairy Journal · doi:10.1016/j.idairyj.2005.10.012 · Cited by 1,737
“Lb. helveticus CP90 proteinase b-cn Lys-Val-Leu-Pro-Val-Pro-(Glu) ACE inhibitory Maeno et al. (1996) Lb. helveticus CPN 4 Whey proteins Tyr-Pro ACE inhibitory Yamamoto et al. (1999)”
BackgroundHypotensive Peptides from Milk Proteins
FitzGerald, R. J., Murray, B. A., & Walsh, D. J. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.4.980s · Cited by 724
The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease
Erdmann, K., Cheung, B. W. Y., & Schröder, H. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.11.010 · Cited by 717
“Furthermore, inhibition of chymase by ACE inhibitory peptides has been suggested to provide an additional antihypertensive effect as well [63].”
BackgroundSeppo, L., Jauhiainen, T., Poussa, T., & Korpela, R. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.2.326 · Cited by 666
“Two other peptides (Tyr-Pro and Lys-Val-Leu-ProVal-Pro-Gln) that were purified and characterized from fermented milk were also shown to have ACE-inhibitory activity in spontaneously hypertensive rats (5, 6).”
BackgroundLactic acid bacteria contribution to gut microbiota complexity: lights and shadows.
Pessione, E. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00086 · Cited by 592
“…but other, casein-derived, antihy-perthensive peptides like alpha s1 casokinin-5 (Phe-Phe-Val-Ala-Pro), alpha s1 casokinin-6 (Thre-Thre-Met-Pro-Leu-Trp), beta-casokinin (Lys-Val-Leu-Pro-Val), and a dipeptide Tyr-Pro, proved to be effective in blood pressure control as well (Yamamoto et al., 1999).”
Metadata
- Authors
- Yamamoto, N., Maeno, M., & Takano, T.
- Affiliations
- Calpis Co., Ltd. (Japan) (JP)
- ORCID
- Yamamoto, Naoyuki
- Venue
- Journal of Dairy Science
- Publisher
- American Dairy Science Association
- Published
- 1999-07
- Volume
- 82
- Issue
- 7
- Pages
- 1388-1393
- ISSN
- 0022-0302 (ISSN-L)
- OpenAlex
- W2032963072
- Cited by
- 266
- References
- 21
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 10 · 2021: 11 · 2020: 7 · 2019: 9 · 2018: 8 · 2017: 5 · 2016: 10 · 2015: 14 · 2014: 12 · 2013: 14 · 2012: 13
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 7133 d)
- Locations
- Journal of Dairy Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Protein Hydrolysis and Bioactive Peptides
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Keywords
- antihypertensive peptides, whey peptides, Lactobacillus helveticus, angiotensin-converting enzyme inhibition, spontaneously hypertensive rats, systolic blood pressure, peptide purification, fermented dairy products
- MeSH terms
- Whey Proteins, Administration, Oral, Angiotensin-Converting Enzyme Inhibitors, Animals, Antihypertensive Agents, Chromatography, High Pressure Liquid, Dipeptides, Fermentation, Food Handling, Male, Milk Proteins, Rats, Inbred SHR, Systole, Yogurt, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. https://app.cochat.ai/papers/10.3168/jds.s0022-0302(99)75364-6
- The paper
- Yamamoto, N., Maeno, M., & Takano, T. (1999). Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. Journal of Dairy Science. https://doi.org/10.3168/jds.s0022-0302(99)75364-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.